CN101951906A - 用于治疗肺病中的健康相关生命质量缺陷的吸入式氨曲南赖氨酸 - Google Patents

用于治疗肺病中的健康相关生命质量缺陷的吸入式氨曲南赖氨酸 Download PDF

Info

Publication number
CN101951906A
CN101951906A CN2008801170106A CN200880117010A CN101951906A CN 101951906 A CN101951906 A CN 101951906A CN 2008801170106 A CN2008801170106 A CN 2008801170106A CN 200880117010 A CN200880117010 A CN 200880117010A CN 101951906 A CN101951906 A CN 101951906A
Authority
CN
China
Prior art keywords
aerosol
domain
day
azli
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2008801170106A
Other languages
English (en)
Chinese (zh)
Inventor
A·蒙特高梅里
M·耶戈
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gilead Sciences Inc
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of CN101951906A publication Critical patent/CN101951906A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN2008801170106A 2007-10-01 2008-09-15 用于治疗肺病中的健康相关生命质量缺陷的吸入式氨曲南赖氨酸 Pending CN101951906A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US99707207P 2007-10-01 2007-10-01
US99707107P 2007-10-01 2007-10-01
US60/997,072 2007-10-01
US60/997,071 2007-10-01
PCT/US2008/076431 WO2009045706A1 (en) 2007-10-01 2008-09-15 Inhaled aztreonam lysine for the treatment of deficits in health-related quality-of life in lung diseases

Publications (1)

Publication Number Publication Date
CN101951906A true CN101951906A (zh) 2011-01-19

Family

ID=40032482

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008801170106A Pending CN101951906A (zh) 2007-10-01 2008-09-15 用于治疗肺病中的健康相关生命质量缺陷的吸入式氨曲南赖氨酸

Country Status (15)

Country Link
US (1) US7973029B2 (enExample)
EP (1) EP2200608A1 (enExample)
JP (1) JP2010540539A (enExample)
KR (1) KR20100093037A (enExample)
CN (1) CN101951906A (enExample)
AR (1) AR068514A1 (enExample)
AU (1) AU2008307268A1 (enExample)
BR (1) BRPI0817636A2 (enExample)
CA (1) CA2701118A1 (enExample)
EA (1) EA201070336A1 (enExample)
IL (1) IL204593A0 (enExample)
MX (1) MX2010003618A (enExample)
NZ (1) NZ584269A (enExample)
TW (1) TW200927193A (enExample)
WO (1) WO2009045706A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104784159A (zh) * 2015-04-15 2015-07-22 苏州惠仁生物科技有限公司 氨曲南粉雾剂的制备方法

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60144291D1 (de) 2000-12-27 2011-05-05 Gilead Sciences Inc Inhalierbares aztreonam zur behandlung und vorbeugung von bakteriellen lungeninfektionen
US7214364B2 (en) 2000-12-27 2007-05-08 Corus Pharma, Inc. Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5152456A (en) * 1989-12-12 1992-10-06 Bespak, Plc Dispensing apparatus having a perforate outlet member and a vibrating device
EP0615470B1 (en) * 1991-12-04 1995-12-13 The Technology Partnership Public Limited Company Fluid droplet production apparatus and method
US6962151B1 (en) * 1999-11-05 2005-11-08 Pari GmbH Spezialisten für effektive Inhalation Inhalation nebulizer
DE19953317C1 (de) 1999-11-05 2001-02-01 Pari Gmbh Inhalationsvernebler
DE60144291D1 (de) * 2000-12-27 2011-05-05 Gilead Sciences Inc Inhalierbares aztreonam zur behandlung und vorbeugung von bakteriellen lungeninfektionen
US7138419B2 (en) * 2000-12-27 2006-11-21 Corus Pharma, Inc. Process for manufacturing bulk solutions and a lyophilized pure α-aztreonam lysinate
US7214364B2 (en) * 2000-12-27 2007-05-08 Corus Pharma, Inc. Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
DE10102846B4 (de) * 2001-01-23 2012-04-12 Pari Pharma Gmbh Aerosolgenerator

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104784159A (zh) * 2015-04-15 2015-07-22 苏州惠仁生物科技有限公司 氨曲南粉雾剂的制备方法

Also Published As

Publication number Publication date
AU2008307268A1 (en) 2009-04-09
WO2009045706A1 (en) 2009-04-09
AR068514A1 (es) 2009-11-18
CA2701118A1 (en) 2009-04-09
IL204593A0 (en) 2010-11-30
EA201070336A1 (ru) 2011-06-30
KR20100093037A (ko) 2010-08-24
NZ584269A (en) 2012-06-29
EP2200608A1 (en) 2010-06-30
TW200927193A (en) 2009-07-01
JP2010540539A (ja) 2010-12-24
US7973029B2 (en) 2011-07-05
BRPI0817636A2 (pt) 2019-09-24
MX2010003618A (es) 2010-04-21
US20090124594A1 (en) 2009-05-14

Similar Documents

Publication Publication Date Title
US8664187B2 (en) Methods of treatment of endobronchial infections
Retsch-Bogart et al. Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis
US5508269A (en) Aminoglycoside formulation for aerosolization
Campbell et al. Use of aerosolized antibiotics in patients with cystic fibrosis
VanDevanter et al. Tobramycin administered by the TOBI® Podhaler® for persons with cystic fibrosis: a review
US7973029B2 (en) Inhaled aztreonam lysine for the treatment of deficits in health-related quality-of-life in lung diseases
JP2010540539A5 (enExample)
Gibson et al. Drug delivery in asthma: a comparison of spacers with a jet nebuliser
US20240342239A1 (en) Treatment of non-cystic fibrosis bronchiectasis
US12178841B2 (en) Treatment of non-cystic fibrosis bronchiectasis
Ibrahim et al. Inhaled Therapy for Other Respiratory Diseases: Cystic Fibrosis and Non-cystic Fibrosis Bronchiectasis
Renee Crowther Labiris et al. Dry Powder versus Intravenous and Nebulized Gentamicin in Cystic Fibrosis and Bronchiectasis: A Pilot Study
CN117897138A (zh) 呼吸系统病症的治疗
Page Nebulizers AHM
Bush et al. 8. NEBULIZERS IN CYSTIC FIBROSIS AND NON-CF BRONCHIECTASIS IN CHILDREN AND ADULTS: THERAPIES

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20110119